细胞冷冻保存市场-按产品类型（冷冻保护剂、设备）、细胞类型（干细胞、卵母细胞和胚胎细胞、精子细胞）、应用（药物发现与开发、再生医学）、最终用途-全球预测，2024 -2032

由于生物样本库技术的进步和干细胞研究应用的不断扩大，全球细胞冷冻保存市场从 2024 年到 2032 年的CAGR将达到 21.5%。随着新实验室的成立，用于各种目的（例如再生医学、药物发现和组织工程）的冷冻细胞的能力增加。这些发展为保存宝贵的细胞资源提供了机会，从而推动了需求。此外，对个人化医疗的日益重视和干细胞疗法的日益采用将进一步促进市场扩张。

例如，2023 年 10 月，专注于细胞和免疫疗法解决方案的合约技术开发和製造组织 (CTDMO) OrganaBio 推出了一个名为细胞处理和冷冻保存 (CPC) 服务的新部门。该专业部门旨在提供分散的临床试验支持，包括根据行业需求量身定制的快速样本处理和资料收集。

细胞冷冻保存市场根据细胞类型、应用和区域进行分类。

由于对辅助生殖技术 (ART) 和生育力保存程序的需求不断增长，到 2032 年，卵母细胞和胚胎细胞部分将占据显着份额。卵母细胞和胚胎细胞对于体外受精 (IVF) 程序和干细胞研究至关重要，可提高采用率。此外，冷冻保存技术的进步提高了储存这些细胞的可行性和成功率，进一步推动了这个市场的成长。

在冷冻保存细胞在再生疗法、组织工程和干细胞研究中的应用不断增加的推动下，到 2032 年，再生医学领域将获得显着的市场份额。此外，冷冻保存技术的进步，以及再生医学研究投资的不断成长，也促进了该领域的成长。随着再生医学成为治疗各种疾病的有前景的领域，对冷冻细胞的需求将激增，巩固该领域的市场领先地位。

亚太细胞冷冻保存产业从 2024 年到 2032 年将呈现显着的复合CAGR，这归因于多种因素，包括慢性病盛行率的增加、医疗保健支出的增加以及对干细胞治疗益处的认识不断提高。此外，该地区不断扩大的生物技术和製药产业，加上政府的支持性倡议，将有助于市场成长。凭藉庞大的人口基数和不断改善的医疗基础设施，亚太地区将保持其在细胞冷冻保存市场的主导地位。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：细胞冷冻保存产业洞察

• 产业生态系统分析
• 技术景观
• 监管环境
• 产业影响力
  • 成长动力
    • 干细胞研究兴起
    • 增加器官移植手术
    • 个性化医疗的成长趋势
    • 增加生物样本库活动
  • 产业陷阱与挑战
    • 冷冻保存技术成本高
    • 道德和监管挑战
• 成长潜力分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：细胞冷冻保存市场规模与预测：依产品类型，2018-2032

• 主要动向：依产品类型
• 冷冻保护剂
  • 二甲亚砜 (DMSO)
  • 乙二醇
  • 甘油
  • 其他代理
• 装置
  • 冰柜
  • 孵化器
  • 液态氮供应罐
  • 超低温保存耗材

第 6 章：细胞冷冻保存市场规模与预测：按细胞类型，2018-2032 年

• 主要动向：依细胞类型
• 干细胞
• 卵母细胞和胚胎细胞
• 精子细胞
• 肝细胞
• 其他细胞类型

第 7 章：细胞冷冻保存市场规模与预测：按应用，2018-2032

• 主要动向：按应用
• 药物发现与开发
• 再生医学
• 器官移植
• 临床研究
• 其他应用

第 8 章：细胞冷冻保存市场规模与预测：依最终用途，2018-2032 年

• 主要动向：依最终用途
• 医院和诊所
• 生物技术和製药公司
• 研究和学术机构
• 合约研究组织 (CRO)

第 9 章：细胞冷冻保存市场规模及预测：按地区划分，2018-2032 年

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Thermo Fisher Scientific Inc.
• Sartorius AG
• PromoCell GmbH
• BioLife Solutions Inc.
• Merck KGaA
• HiMedia Laboratories
• Creative Biolabs
• Corning Incorporated
• GE Healthcare
• Danaher Corporation

Global Cell Cryopreservation Market will register a 21.5% CAGR from 2024 to 2032 due to advancements in biobanking technologies and the expanding applications of stem cell research. With the launch of new laboratories, there's an increased capacity for cryopreserving cells for various purposes, such as regenerative medicine, drug discovery, and tissue engineering. These developments offer opportunities for preserving valuable cell resources, driving demand. Additionally, the growing emphasis on personalized medicine and the rising adoption of stem cell-based therapies will further contribute to the market expansion.

For instance, in October 2023, OrganaBio, a contract technology development and manufacturing organization (CTDMO) focusing on cell and immunotherapy solutions, introduced a new division called Cell Processing and Cryopreservation (CPC) Services. This specialized division aims to offer decentralized clinical trial support, encompassing prompt sample processing and data capture tailored to the needs of the industry.

The cell cryopreservation market is classified based on cell type, application, and region.

The oocytes and embryotic cells segment will capture a remarkable share by 2032, driven by the increasing demand for assisted reproductive technologies (ART) and fertility preservation procedures. Oocytes and embryotic cells are crucial for in vitro fertilization (IVF) procedures and stem cell research, prompting higher adoption rates. Moreover, advancements in cryopreservation techniques have improved the viability and success rates of storing these cells, further fueling the growth of this segment in the market.

The regenerative medicine segment will achieve notable market share by 2032, fueled by the increasing applications of cryopreserved cells in regenerative therapies, tissue engineering, and stem cell research. Additionally, advancements in cryopreservation techniques, in line with growing investments in regenerative medicine research, bolster the segment's growth. With regenerative medicine emerging as a promising field for treating various medical conditions, the demand for cryopreserved cells will surge, solidifying the segment's leading position in the market.

Asia Pacific cell cryopreservation industry will demonstrate a significant CAGR from 2024 to 2032, attributed to several factors, including the increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness about the benefits of stem cell therapy. Moreover, the region's expanding biotechnology and pharmaceutical industries, in tandem with supportive government initiatives, will contribute to market growth. With a large population base and improving healthcare infrastructure, Asia Pacific will maintain its prominence in the cell cryopreservation market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Base estimates and workings
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global cell cryopreservation market 360 degree synopsis, 2018 - 2032
  • 2.1.1 Regional trends
  • 2.1.2 Product type trends
  • 2.1.3 Cell type trends
  • 2.1.4 Application trends
  • 2.1.5 End-use trends

Chapter 3 Cell Cryopreservation Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Technology landscape
• 3.3 Regulatory landscape
• 3.4 Industry impact forces
  • 3.4.1 Growth drivers
    • 3.4.1.1 Rising stem cell research
    • 3.4.1.2 Increasing organ transplantation procedures
    • 3.4.1.3 Growing trend towards personalized medicine
    • 3.4.1.4 Increasing biobanking activities
  • 3.4.2 Industry pitfalls and challenges
    • 3.4.2.1 High cost of cryopreservation technologies
    • 3.4.2.2 Ethical and regulatory challenges
• 3.5 Growth potential analysis
  • 3.5.1 By product type
  • 3.5.2 By cell type
  • 3.5.3 By application
  • 3.5.4 By end-use
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis, 2023
• 4.3 Competitive analysis of major market players, 2023
• 4.4 Competitive positioning matrix, 2023
• 4.5 Strategic outlook matrix, 2023

Chapter 5 Cell Cryopreservation Market Size and Forecast, By Product Type, 2018-2032 (USD Million)

• 5.1 Key trends, by product type
• 5.2 Cryoprotectant agents
  • 5.2.1 Dimethyl sulfoxide (DMSO)
  • 5.2.2 Ethylene glycol
  • 5.2.3 Glycerol
  • 5.2.4 Other agents
• 5.3 Equipment
  • 5.3.1 Freezers
  • 5.3.2 Incubators
  • 5.3.3 Liquid nitrogen supply tanks
  • 5.3.4 Cryopreservation consumables

Chapter 6 Cell Cryopreservation Market Size and Forecast, By Cell Type, 2018-2032 (USD Million)

• 6.1 Key trends, by cell type
• 6.2 Stem cells
• 6.3 Oocytes and embryotic cells
• 6.4 Sperm cells
• 6.5 Hepatocytes
• 6.6 Other cell types

Chapter 7 Cell Cryopreservation Market Size and Forecast, By Application, 2018-2032 (USD Million)

• 7.1 Key trends, by application
• 7.2 Drug discovery and development
• 7.3 Regenerative medicine
• 7.4 Organ transplantation
• 7.5 Clinical research
• 7.6 Other applications

Chapter 8 Cell Cryopreservation Market Size and Forecast, By End-use, 2018-2032 (USD Million)

• 8.1 Key trends, by end-use
• 8.2 Hospitals and clinics
• 8.3 Biotechnology and pharmaceutical companies
• 8.4 Research and academic institutes
• 8.5 Contract research organizations (CROs)

Chapter 9 Cell Cryopreservation Market Size and Forecast, By Region, 2018-2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Thermo Fisher Scientific Inc.
• 10.2 Sartorius AG
• 10.3 PromoCell GmbH
• 10.4 BioLife Solutions Inc.
• 10.5 Merck KGaA
• 10.6 HiMedia Laboratories
• 10.7 Creative Biolabs
• 10.8 Corning Incorporated
• 10.9 GE Healthcare
• 10.10 Danaher Corporation